Last updated on December 2018

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home


Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)

Detailed Study Description

This is a 6 month, multi-center, randomized, parallel, adaptive study in type 1 diabetes with a 6 month continuation period. The study will have three periods:

  1. Run-in Period: The run-in period can be up to 60 days during which time a blinded CGM sensor will be worn for two weeks.
  2. Study Period: There will be a 6 month randomized study period with two arms: The HCL system and Control.
  3. Continuation Period: There will be a 6 month continuation period during which time all subjects will use the HCL system with Auto Mode.

Up to 1500 subjects will be enrolled in order to have 1120 subjects complete the study. Up to 70 investigational Centers in the US, Europe and Canada will be enrolled.

Clinical Study Identifier: NCT02748018

Contact Investigators or Research Sites near you

Start Over

Kevin Kaiserman, MD

SoCal Diabetes
Torrance, CA United States
  Connect »

Mark Christiansen, MD

Diablo Clinical Research
Walnut Creek, CA United States
  Connect »

Robert Slover, MD

Barbara Davis Center
Aurora, CO United States
  Connect »

Bruce Bode, MD

Atlanta Diabetes Associates
Atlanta, GA United States
  Connect »

John Reed, MD

Endocrine Research Solutions
Roswell, GA United States
  Connect »

Rodica Pop-Busui, MD

University of Michigan
Ann Arbor, MI United States
  Connect »

George Grunberger, MD

Grunberger Diabetes Institute
Bloomfield Hills, MI United States
  Connect »

Luis Casaubon, MD

Texas Diabetes & Endocrinology
Austin, TX United States
  Connect »

Ronald Brazg, MD

Rainier Clinical Research
Renton, WA United States
  Connect »

Irl Hirsch, MD

University of Washington
Seattle, WA United States
  Connect »

Amy Criego, MD

Initernational Diabetes Center
Minneapolis, MN United States
  Connect »

Anders Carlson, MD

International Diabetes Center
Minneapolis, MN United States
  Connect »

Yogish Kudva, MD

Mayo Clinic
Rochester, MN United States
  Connect »

Athena Philis-Tsimikas, MD

Scripps Health System
La Jolla, CA United States
  Connect »

David Liljenquist, MD

Rocky Mountain Diabetes
Idaho Falls, ID United States
  Connect »

Anuj Bhargava, MD

IDERC
Des Moines, IA United States
  Connect »

Maria Redondo, MD

Texas Children's Hospital / Baylor University
Houston, TX United States
  Connect »

Bruce Buckingham, MD

Stanford University
Palo Alto, CA United States
  Connect »

Janet McGill, MD

Washington University St. Louis
Saint Louis, MO United States
  Connect »

Ruth Weinstock, MD

SUNY Upstate Medical University
Syracuse, NY United States
  Connect »

Kurt Griffin, MD

Sanford Health
Sioux Falls, SD United States
  Connect »

Angela Girelli, MD

A.S.S.T. Spedali Civili
Brescia, Italy
  Connect »

Johan Jendle, MD

Dept Internal Medicine, rebro University Hospital
Örebro, Sweden
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.